CD79A and breast cancer: A comparison of 48 postmenopausal breast cancer cases (75% stage 0–I, 88% estrogen-receptor positive) to 48 contemporaneous, postmenopausal, normal-mammogram, age-matched controls revealed that breast cancer cases had significant estrogen-independent associations with the IgA-positive and IgA-negative gut microbiota [76].